HOOKIPA Pharma Inc. is a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform.

As of 06/24/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/18/2019
Outstanding shares:  50,872,734
Average volume:  653,660
Market cap:   $91,570,921
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJ5K4M7
Valuation   (See tab for details)
PE ratio:   -1.15
PB ratio:   0.64
PS ratio:   17.15
Return on equity:   -51.64%
Net income %:   -1,430.62%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy